The legal and administrative systems used to manage the classification, production, distribution, prescribing, and availability of controlled substances. These regulatory frameworks aim to ensure that substances with psychoactive properties are safely produced, distributed, and used for legitimate medical and scientific purposes, while preventing diversion, misuse, and illegal distribution. Regulatory control may include drug scheduling, licensing of manufacturers and prescribers, prescription monitoring systems, import and export controls, and pharmaceutical supply oversight. These mechanisms help balance access to essential medicines with the protection of public health and safety.
Regulatory Control of Substances
Is it time for Bangladesh to rejig its rehabilitation policies on mobile addiction in children
Just the other day a distraught parent came into my office looking for a rehab center for their teen. The crisis was not substance abuse but smartphone addiction. The situation has reached a level where the child experiences a great deal of...
Bangladesh’s Youth Victims of Addiction: A Hidden Crisis Behind the Number
Introduction In Bangladesh, drug addiction has ceased to be only a law enforcement problem. It has become a serious social and psychological disaster. Its principal victims are the most promising population of the country: the youth. A...
The New Drug World: Strengthening Collaboration to Address Synthetic Drug Threats
This report examines how the rapid growth of synthetic drug markets is transforming the global drug landscape and challenging traditional approaches to drug control. Unlike plant-based drugs such as cocaine and heroin, synthetic drugs can...
Bangladesh’s Youth Victims of Addiction: A Hidden Crisis Behind the Number
Introduction In Bangladesh, drug addiction has ceased to be only a law enforcement problem. It has become a serious social and psychological disaster. Its principal victims are the most promising population of the country: the youth. A...
Beyond Borders: Is the Synthetic Drug Crisis Outrunning Our Public Health Infrastructure
I had the chance to review a compelling research presentation hosted by the International Society of Substance Use Professionals (ISSUP), which revealed significant data from a large-scale study on methamphetamine (‘Crystal Meth/Ice’) use...
The Invisible Crisis: Female Substance Use Disorder, Psychological Trauma, and Policy Gaps in Bangladesh.
Although the public health theme often dominates conversations on Substance Use Disorder (SUD) in Bangladesh, an important and strongly gendered factor is dangerously obscured: female substance use. What was once a hushed family secret...
Suboxone, Kratom, and 7-Hydroxymitragynine (7-OH): A Guide to Withdrawal Risks, Buprenorphine Treatment, and Clinical Considerations
Kratom, 7-OH, and Suboxone: Withdrawal, Blocking Effects, and Treatment Options Quick answer: Yes, Suboxone can block the effects of kratom because buprenorphine binds strongly to the brain’s opioid receptors. However, taking Suboxone too...
Advancing Drug Policy, Mental Health, and Tobacco Control
From Stigma to Treatment: A Forum on Medical Cannabis Legalization in the Philippines The University of the Philippines Law Center Institute of Human Rights (UP IHR) hosted the public forum "From Stigma to Treatment: A Forum on Medical...
Drug production and precursors — EUDA ongoing activities
The European Union Drugs Agency (EUDA) continues to monitor illicit drug production and precursor chemicals across Europe to improve understanding of how drug markets are evolving. Production within the European Union is primarily focused...
Highlights from the 2026 UNODC World Drug Report
This webinar highlighted key findings from the 2026 edition of the UNODC World Drug Report. The session was presented by Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section at the United Nations Office on Drugs and Crime (UNODC).